Susquehanna Reiterates Neutral Rating for Humana Inc. (HUM)
Humana Inc. (NYSE:HUM)‘s stock had its “neutral” rating restated by research analysts at Susquehanna in a note issued to investors on Thursday. They presently have a $180.00 price objective on the insurance provider’s stock. Susquehanna’s price objective would indicate a potential upside of 5.37% from the company’s current price.
A number of other research firms have also commented on HUM. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $198.00 target price for the company in a report on Tuesday, October 4th. Credit Suisse Group AG reissued a “hold” rating on shares of Humana in a research report on Tuesday, June 28th. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a research report on Saturday, July 9th. Royal Bank Of Canada lifted their price target on shares of Humana from $220.00 to $224.00 and gave the stock an “outperform” rating in a research report on Friday, July 22nd. Finally, Leerink Swann reissued an “outperform” rating on shares of Humana in a research report on Tuesday, June 21st. Seven investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $200.50.
Humana (NYSE:HUM) opened at 170.82 on Thursday. The firm’s 50-day moving average is $175.94 and its 200 day moving average is $175.74. Humana has a 52-week low of $150.00 and a 52-week high of $191.65. The firm has a market capitalization of $25.46 billion, a P/E ratio of 26.24 and a beta of 0.90.
Humana (NYSE:HUM) last released its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The firm earned $14 billion during the quarter, compared to analyst estimates of $13.59 billion. During the same quarter in the previous year, the business earned $1.67 EPS. The business’s quarterly revenue was up 2.0% compared to the same quarter last year. Equities analysts anticipate that Humana will post $9.24 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be paid a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 annualized dividend and a dividend yield of 0.68%. Humana’s dividend payout ratio is presently 18.18%.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in HUM. National Pension Service raised its position in Humana by 8.3% in the third quarter. National Pension Service now owns 109,373 shares of the insurance provider’s stock valued at $19,347,000 after buying an additional 8,409 shares in the last quarter. Stock Yards Bank & Trust Co. raised its position in Humana by 5.1% in the third quarter. Stock Yards Bank & Trust Co. now owns 12,799 shares of the insurance provider’s stock valued at $2,264,000 after buying an additional 620 shares in the last quarter. Capstone Asset Management Co. raised its position in Humana by 0.9% in the third quarter. Capstone Asset Management Co. now owns 13,373 shares of the insurance provider’s stock valued at $2,366,000 after buying an additional 124 shares in the last quarter. Creative Planning raised its position in Humana by 9.4% in the third quarter. Creative Planning now owns 7,174 shares of the insurance provider’s stock valued at $1,269,000 after buying an additional 619 shares in the last quarter. Finally, Daiwa SB Investments Ltd. raised its position in Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares in the last quarter. Institutional investors own 93.24% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.